IMEGLIMON 1000 Tablet is prescribed for managing type 2 diabetes mellitus. It is intended to be used alongside a balanced diet and consistent physical activity to effectively regulate blood sugar levels. Proper management of blood sugar is critical in preventing severe complications associated with diabetes, such as renal damage and vision loss. This medication is typically recommended when lifestyle changes and other treatments alone are inadequate to maintain optimal blood sugar control. Depending on individual health requirements and blood glucose measurements, your healthcare provider may prescribe IMEGLIMON 1000 either as a standalone therapy or in conjunction with other medications for diabetes. It can be ingested with or without meals, and the specific dosage will be tailored to your individual circumstances. For maximum efficacy, it is essential to take this medication consistently at the same time every day. Do not discontinue use without consulting your healthcare provider first. Maintaining adherence to your prescribed dietary and exercise regimen is crucial while using this medication, as lifestyle factors significantly influence diabetes management. Potential side effects include low blood sugar (hypoglycemia), constipation, nausea, abdominal pain, indigestion, and unintended weight loss. Recognizing the signs of low blood sugar—such as dizziness, excessive sweating, faintness, and dry mouth—is vital, and having fast-acting sugars like glucose tablets on hand may be beneficial for symptom management. If side effects persist or cause concern, please reach out to your healthcare professional. Before starting this medication, inform your doctor of any previous kidney, heart, or pancreatic conditions, as well as all medications you are currently taking. Regular monitoring of kidney function and blood sugar levels may be necessary during treatment to ensure safety and effectiveness.
-43%

IMEGLIMON 1000
Original price was: ₹262.50.₹150.00Current price is: ₹150.00.
Add to cart
Buy Now

Reviews
There are no reviews yet.